24/7 Live
Raleigh
Durham
Fayetteville
Surrounding Area
Welcome, Mickey
mickey@disney.com
Manage MyDisney Account
Log Out
ABC11 Together
ABC11 Raleigh Christmas Parade
Latest 7-day forecast
Climate Ready
Submit a News Tip
ABC11 Troubleshooter
weight loss
Share
Tweet
Email
FDA approves 1st medication for obstructive sleep apnea
The new approval means that insurance providers will likely cover the medication for people with sleep apnea and obesity.
US obesity rates drop for 1st time in a decade
Weight-loss drugs could help treat addiction
How potent are online weight loss meds?
Biden proposes Medicare and Medicaid cover costly weight-loss drugs
Jelly Roll's chef opens up about singer's 100-pound weight loss
Ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's: Study
More Stories
Weight loss drugs like Ozempic may help reduce overdose risks: Study
Congressional hearing on weight loss drug puts NC in spotlight
Ozempic producer CEO in hot seat in congressional hearing
Obesity prevalence among US adults falls slightly to 40%: CDC
Eli Lilly to sell Zepbound directly to consumers without insurance
Some people are overdosing on semaglutide, FDA warns
Robeson County educator motivated to lose weight for his students
Nearly half of US adult cancer deaths could be prevented, study finds
Pfizer targets obesity with new once-daily Danuglipron drug
Weight-loss, diabetes meds linked to lower risk of some cancers: Study
Eli Lilly warns about dangers of fake Mounjaro, Zepbound
New Wegovy clinical trial finds surprising benefits beyond weight loss
Show More
Show Fewer
More Stories
US obesity rates drop for 1st time in a decade
Weight-loss drugs could help treat addiction
How potent are online weight loss meds?
Biden proposes Medicare and Medicaid cover costly weight-loss drugs
Jelly Roll's chef opens up about singer's 100-pound weight loss
Ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's: Study
Weight loss drugs like Ozempic may help reduce overdose risks: Study
Congressional hearing on weight loss drug puts NC in spotlight
Ozempic producer CEO in hot seat in congressional hearing
Obesity prevalence among US adults falls slightly to 40%: CDC
Eli Lilly to sell Zepbound directly to consumers without insurance
Some people are overdosing on semaglutide, FDA warns
Robeson County educator motivated to lose weight for his students
Nearly half of US adult cancer deaths could be prevented, study finds
Pfizer targets obesity with new once-daily Danuglipron drug
Weight-loss, diabetes meds linked to lower risk of some cancers: Study
Eli Lilly warns about dangers of fake Mounjaro, Zepbound
New Wegovy clinical trial finds surprising benefits beyond weight loss
Show More
Show Fewer